SCHEMBL7917319

SCHEMBL7917319

CC(C)NC(C)c1c[nH]c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.61
FFAR1 O14842 2/20 0.61
HTR2A P28223 2/20 0.56
HTR2C P28335 2/20 0.56
HTR2B P41595 2/20 0.56
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
CYP2D6 P10635 1/20 0.48
KCNH2 Q12809 1/20 0.48
ATM Q13315 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
SRC P12931 1/20 0.45
MAPT P10636 4/20 0.45
NR3C1 P04150 1/20 0.44
PGR P06401 1/20 0.44
NR3C2 P08235 1/20 0.44
AR P10275 1/20 0.44
ALDH1A1 P00352 3/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30771660 0.84 GPR84 (0.62) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL30771661 0.84 GPR84 (0.62) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL1253068 0.84 GPR84 (0.62) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL19410688 0.80 GPR84 (0.61) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL4666383 0.79 GPR84 (0.60) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL11171165 0.79 VDR (0.58) GPR84FFAR1HTR2AHTR2CHTR2B
Vibrindole A SCHEMBL5960513 0.79 GPR84 (0.71) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL30626309 0.79 GPR84 (0.71) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL255420 0.79 GPR84 (0.71) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL2548826 0.77 GPR84 (0.54) GPR84FFAR1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225352-B1 USEFUL AS AGENTS IN THE TREATMENT OF CANCER, ALZHEIMERS DISEASE, THROMBOSIS, INFLAMMATORY DISEASES, AND BACTERIAL RESISTANCE WARNER-LAMBERT COMPANY 2001-05-01 US claimed
EP-1401449-B1 TETRACYCLIC COMPOUNDS AS PDE5-INHIBITORS LILLY ICOS LLC (US) 2007-04-25 EP disclosed
US-6225352-B1 USEFUL AS AGENTS IN THE TREATMENT OF CANCER, ALZHEIMERS DISEASE, THROMBOSIS, INFLAMMATORY DISEASES, AND BACTERIAL RESISTANCE WARNER-LAMBERT COMPANY 2001-05-01 US disclosed